We are live on ! Find out more
JSPRW icon

Japer Therapeutics Warrants
JSPRW

15 hedge funds and large institutions have $554K invested in Japer Therapeutics Warrants in 2022 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 15 → 15 (0)

0% more first-time investments, than exits

New positions opened: 1 | Existing positions closed: 1

33% less repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 3

81% less capital invested

Capital invested by funds: $2.97M → $554K (-$2.42M)

Holders
15
Holders Change
–
Holders Change %
0%
% of All Funds
0.24%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
2
Reduced
3
Closed
1
Calls
$228K
Puts
–
Net Calls
+$228K
Net Calls Change
-$304K

Top Buyers

Rank Fund Capital Flow
1
ICM
Ionic Capital Management
New York
+$15K
2
SIA
SkyView Investment Advisors
New Jersey
+$167

Top Sellers

Rank Fund Capital Flow
1
RCM
Rivernorth Capital Management
Florida
-$97K
2
ICMH
Integrity Capital Management (HK)
Hong Kong
-$24.8K
3
UBS Group
UBS Group
Switzerland
-$558
4
WAM
Wolverine Asset Management
Illinois
-$36
Name Holding Trade Value Shares
Change 		Change in
Stake
HCM
1
Highbridge Capital Management
New York
$149K – – –
ICM
2
Ionic Capital Management
New York
$121K +$15K +26,969 +8%
OCAM
3
Owl Creek Asset Management
New York
$97K – – –
TCM
4
Tenor Capital Management
New York
$65K – – –
SCM
5
Shaolin Capital Management
Florida
$33K – – –
PFM
6
Privium Fund Management
Netherlands
$25K – – –
ZA
7
Zazove Associates
Nevada
$22K +$36.5K +65,456 New
EPM
8
Equitec Proprietary Markets
Illinois
$12K – – –
HF
9
HRT Financial
New York
$10K – – –
Walleye Capital
10
Walleye Capital
New York
$7K – – –
Walleye Trading
11
Walleye Trading
New York
$4K – – –
YCM
12
Yakira Capital Management
Connecticut
$4K – – –
ICMH
13
Integrity Capital Management (HK)
Hong Kong
$2K -$24.8K -44,561 -89%
WAM
14
Wolverine Asset Management
Illinois
$2K -$36 -65 -0.8%
UBS Group
15
UBS Group
Switzerland
$1K -$558 -1,000 -21%
RCM
16
Rivernorth Capital Management
Florida
– -$97K -65,707 Closed
SIA
17
SkyView Investment Advisors
New Jersey
– +$167 +300 +15,000%

JSPRW Hedge Fund Activity: Q1 2022 in Review

15 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Japer Therapeutics Warrants (JSPRW) for Q1 2022, worth a combined $554K — down 81% from $2.97M a quarter earlier.

Fund positioning in JSPRW was balanced in Q1 2022: 1 fund opened new positions, 1 closed out, 2 added to existing stakes and 3 trimmed.

The largest buyer was Ionic Capital Management, adding an estimated $15K. The largest seller was Rivernorth Capital Management, exiting entirely with an estimated $97K sold.

  • 15 institutional investors held Japer Therapeutics Warrants (JSPRW) as of Q1 2022, unchanged from Q4 2021.
  • Funds reported $554K of Japer Therapeutics Warrants stock for Q1 2022, down 81% quarter-over-quarter.
  • 1 fund opened new Japer Therapeutics Warrants positions in Q1 2022 and 1 closed out, a net change of 0 holders.
  • The largest Japer Therapeutics Warrants buyer in Q1 2022 was Ionic Capital Management, an estimated $15K added.
  • The largest Japer Therapeutics Warrants seller in Q1 2022 was Rivernorth Capital Management, an estimated $97K sold.

Based on aggregated 13F filings for Q1 2022.